Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIFE trial of aspirin and low-molecular-weight heparin for unexplained recurrent pregnancy loss
NL-OMON26868Recruiting
- Start
- Feb 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in recurrent miscarriage (RPL) and stillbirth comparing Placebo, Aspirin and Aspirin plus low-molecular-weight heparin (3 arms). Primary endpoint: Live birth rate. Started Feb 2004; status: recruiting.
02
Drugs
aspirinlow molecular weight heparin calcium
03
Conditions
recurrent miscarriage (RPL)stillbirth
Beyond the preview
Go deeper on NL-OMON26868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26868.